Cost savings associated with extended battery longevity in cardiac resynchronization therapy defibrillators.

ABSTRACT:

Background

Cardiac resynchronization therapy-defibrillators (CRT-D) are devices established as treatment for symptomatic heart failure patients at risk of sudden cardiac death. Battery depletion poses a significant clinical and economic burden; extended service life may reduce costs because of generator changes and associated complications.

Objective

This study estimated cost-savings associated with extended battery longevity in Medicare patients receiving CRT-D implantation.

Methods

A decision tree was used to explore 3 battery capacities: 1.0 ampere-hours (Ah), 1.6Ah, and 2.1Ah. Yearly risk of all-cause mortality, device-related complications, and end of battery life were estimated. Over 6 years, estimated costs included device implantation, replacement, follow-up a

SUBMITTER: Williams JL 

PROVIDER: S-EPMC11624373 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature